The CRP–albumin–lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system

Abstract Reliable biomarkers are critical for improving overall survival (OS) and guiding therapeutic strategies in liver cancer. This study evaluated the CRP–albumin–lymphocyte (CALLY) index—a composite indicator of systemic inflammation, nutritional status, and immune function—as a prognostic tool...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong Zhao, Bing Yin, Xiang-Rui Li, Xiao-Yue Liu, Zhao-Ting Bu, Han-Ping Shi
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-03985-7
Tags: Add Tag
No Tags, Be the first to tag this record!